Study group parameters (n = 196) | Median | Q1 | Q3 |
---|---|---|---|
Age of subjects at the time of their registration at SC (years) | 31.9 | 26.8 | 39.9 |
Age of subjects at study inclusion (years) | 41.0 | 34.4 | 49.0 |
BMI prior to study inclusion (kg/m2) | 23.6 | 21.3 | 25.9 |
BP prior to study inclusion: systolic/diastolic (mm Hg) | 136/88 | 127/80 | 145/91 |
ART duration (years) | 4.3 | 2.5 | 10.9 |
CD4+ cell count at registration at SC (cells/mcL) | 350 | 192 | 526 |
CD4+ cell count prior to study inclusion (cells/mcL) | 550 | 424 | 704 |
CRP levels at registration at SC (IU) | 5.0 | 5.0 | 9.0 |
CRP levels prior to study inclusion (IU) | 6.0 | 5.0 | 9.0 |
Serum HGB at registration at SC (g/dL) | 14.2 | 12.8 | 15.1 |
Serum HGB prior to study inclusion (g/dL) | 15.0 | 13.9 | 15.9 |